Ontology highlight
ABSTRACT:
SUBMITTER: Hong S
PROVIDER: S-EPMC5069603 | biostudies-literature | 2016 May
REPOSITORIES: biostudies-literature
Diabetes, obesity & metabolism 20160318 5
We assessed the 24-week efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus (T2DM) that was inadequately controlled with diet and exercise. The present study was designed as a multicentre, randomized, double-blind, placebo-controlled, parallel-group, phase III study. Patients (n = 142) were randomized 2 : 1 into two different treatment groups as follows: 99 received teneligliptin (20 mg) and 43 received placebo. The pri ...[more]